Financiën Thermo Fisher Scientific Inc.
Aandelen
TMO
US8835561023
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
552,86 USD | -3,26% |
|
-6,89% | +6,27% |
Voorlopige winst- en verliesrekening: Thermo Fisher Scientific Inc.
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Omzet 1 | 25.542 | 32.218 | 39.211 | 44.915 | 42.857 | 42.879 | 43.909 | 46.995 |
Variatie | - | 26,14% | 21,71% | 14,55% | -4,58% | 0,05% | 2,4% | 7,03% |
EBITDA 1 | 6.537 | 10.214 | 12.969 | 11.971 | 10.878 | 10.863 | 11.397 | 12.416 |
Variatie | - | 56,25% | 26,97% | -7,7% | -9,13% | -0,14% | 4,92% | 8,94% |
Bedrijfsresultaat (EBIT) 1 | 5.973 | 9.556 | 12.138 | 10.985 | 9.810 | 9.707 | 10.313 | 11.249 |
Variatie | - | 59,99% | 27,02% | -9,5% | -10,7% | -1,05% | 6,24% | 9,08% |
Betaalde rente 1 | -676 | -553 | -536 | -726 | -1.375 | -1.390 | -1.177 | -1.023 |
Resultaat voor belastingen (EBT) 1 | 4.070 | 7.225 | 8.841 | 7.835 | 6.298 | 7.037 | 7.671 | 8.931 |
Variatie | - | 77,52% | 22,37% | -11,38% | -19,62% | 11,73% | 9,01% | 16,43% |
Nettowinst (verlies) 1 | 3.696 | 6.375 | 7.725 | 6.950 | 5.995 | 6.335 | 6.805 | 7.732 |
Variatie | - | 72,48% | 21,18% | -10,03% | -13,74% | 5,67% | 7,42% | 13,63% |
Datum van publicatie | 30/01/20 | 1/02/21 | 2/02/22 | 1/02/23 | 31/01/24 | 30/01/25 | - | - |
Balansprognose: Thermo Fisher Scientific Inc.
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Nettoschuld 1 | 15.353 | 11.410 | 30.393 | 25.964 | 26.840 | 27.266 | 22.069 | 16.300 |
Variatie | - | -25,68% | 166,37% | -14,57% | 3,37% | 1,59% | -15,03% | -26,14% |
Datum van publicatie | 30/01/20 | 1/02/21 | 2/02/22 | 1/02/23 | 31/01/24 | 30/01/25 | - | - |
Verwachte kasstroom: Thermo Fisher Scientific Inc.
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 926 | 1.474 | 2.523 | 2.243 | 1.479 | 1.400 | 1.524 | 1.648 |
Variatie | - | 59,18% | 71,17% | -11,1% | -34,06% | -5,34% | 10,6% | 8,17% |
Vrije kasstroom (FCF) 1 | 4.047 | 6.815 | 7.020 | 6.935 | 6.927 | 7.324 | 7.926 | 9.700 |
Variatie | - | 68,4% | 3,01% | -1,21% | -0,12% | 5,73% | 14,4% | 22,38% |
Datum van publicatie | 30/01/20 | 1/02/21 | 2/02/22 | 1/02/23 | 31/01/24 | 30/01/25 | - | - |
Verwachte financiële ratio's: Thermo Fisher Scientific Inc.
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
EBITDA-marge (%) | 25,59% | 31,7% | 33,07% | 26,65% | 25,38% | 25,33% | 25,96% | 26,42% |
EBIT-marge (%) | 23,39% | 29,66% | 30,96% | 24,46% | 22,89% | 22,64% | 23,49% | 23,94% |
EBT-marge (%) | 15,93% | 22,43% | 22,55% | 17,44% | 14,7% | 16,41% | 17,47% | 19% |
Nettomarge (%) | 14,47% | 19,79% | 19,7% | 15,47% | 13,99% | 14,77% | 15,5% | 16,45% |
FCF-marge (%) | 15,84% | 21,15% | 17,9% | 15,44% | 16,16% | 17,08% | 18,05% | 20,64% |
Vrije kasstroom/nettoresultaat (%) | 109,5% | 106,9% | 90,87% | 99,78% | 115,55% | 115,61% | 116,47% | 125,44% |
Winstgevendheid | ||||||||
ROA | 8,7% | 12,26% | 9,43% | 9,52% | 8,54% | 8,55% | 8,21% | 8,87% |
ROE | 17,38% | 24,34% | 26,52% | 21,61% | 18,43% | 17,4% | 17,1% | 17,11% |
Financiële gezondheid | ||||||||
Hefboom (schuld/ebitda) | 2,35x | 1,12x | 2,34x | 2,17x | 2,47x | 2,51x | 1,94x | 1,31x |
Schuld/vrije kasstroom | 3,79x | 1,67x | 4,33x | 3,74x | 3,87x | 3,72x | 2,78x | 1,68x |
Kapitaalintensiteit | ||||||||
Kapitaaluitgaven/omzet (%) | 3,63% | 4,58% | 6,43% | 4,99% | 3,45% | 3,27% | 3,47% | 3,51% |
CAPEX / EBITDA (%) | 14,17% | 14,43% | 19,45% | 18,74% | 13,6% | 12,89% | 13,37% | 13,27% |
CAPEX / FCF (%) | 22,88% | 21,63% | 35,94% | 32,34% | 21,35% | 19,12% | 19,22% | 16,99% |
Bestanddelen per aandeel | ||||||||
Kasstroom per aandeel 1 | 12,34 | 20,77 | 24,04 | 23,23 | 21,66 | 22,63 | 24,97 | 27,56 |
Variatie | - | 68,35% | 15,71% | -3,35% | -6,75% | 4,45% | 9,6% | 10,36% |
Dividend per aandeel 1 | 0,76 | 0,88 | 1,04 | 1,2 | 1,4 | 1,511 | 1,598 | 1,719 |
Variatie | - | 15,79% | 18,18% | 15,38% | 16,67% | 7,96% | 5,75% | 7,55% |
Nettoactief per aandeel 1 | 74,19 | 86,48 | 103,4 | 112,6 | 120,9 | 130,6 | 142,8 | 155,8 |
Variatie | - | 16,57% | 19,58% | 8,89% | 7,33% | 8,04% | 9,31% | 9,13% |
WPA 1 | 9,17 | 15,96 | 19,46 | 17,63 | 15,45 | 16,53 | 18,24 | 20,71 |
Variatie | - | 74,05% | 21,93% | -9,4% | -12,37% | 6,99% | 12,05% | 13,55% |
Aantal aandelen (in duizend) | 400.991 | 396.335 | 394.048 | 394.048 | 386.372 | 382.500 | 382.500 | 382.500 |
Datum van publicatie | 30/01/20 | 1/02/21 | 2/02/22 | 1/02/23 | 31/01/24 | 30/01/25 | - | - |
2024 | 2025 * | |
---|---|---|
P/E-ratio | 31,5x | 30,3x |
PBR-ratio | 4,23x | 3,87x |
EV/omzet | 5,28x | 5,32x |
Dividendrendement | 0,27% | 0,29% |
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
